Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Fgf7em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Fgf7em1/Cya

Common Name
Fgf7-KO
Product ID
S-KO-20416
Backgroud
C57BL/6JCya
Strain ID
KOCMP-14178-Fgf7-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Fgf7-KO Mouse (Catalog S-KO-20416) were purchased from Cyagen.”
KO Models
MAPK signaling pathway
PI3K-Akt signaling pathway
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
MAPK signaling pathway
PI3K-Akt signaling pathway
Basic Information
Strain Name
Fgf7-KO
Strain ID
KOCMP-14178-Fgf7-B6J-VA
Gene Name
Fgf7
Product ID
S-KO-20416
Gene Alias
Kgf, Fgf5b
Background
C57BL/6JCya
Gene Full Name
fibroblast growth factor 7
Modification
Conventional knockout
NCBI ID
14178 (Mouse)
Phenotype
MGI:95521
Chromosome
Chr 2 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000064794
NCBI Transcript ID
NM_008008
Target Region
Exon 3
Size of Effective Region
~0.8 kb
Overview of Gene Research
Fgf7, also known as keratinocyte growth factor, is a member of the fibroblast growth factor (FGF) family. It is secreted exclusively by the mesenchyme and specifically activates the "b" isoforms of FGFR1 (FGFR1b) and FGFR2 (FGFR2b) in the overlying epithelium, contributing to the development of essentially all organs, glands, and limbs [2].

Single-cell RNA-seq analysis revealed that Fgf7 mediates a novel interaction between muscle fibro-adipogenic progenitors (FAPs) and satellite cells. Exogenous FGF7 enhances satellite cell proliferation, benefits muscle regeneration, and counteracts age-related myopathy [1]. FGF7 can also enhance the expression of ACE2 in human islet organoids, facilitating SARS-CoV-2 infection and impairing insulin secretion [3]. In osteoblasts, FGF7 increases the expression of E11, promotes dendrites elongation and functional gap junctions formation [4]. In fusion-positive rhabdomyosarcomas, FGF7-FGFR2 autocrine signaling increases growth and chemoresistance [5]. FGF7 peptide (FGF7p) can mitigate bladder urothelial injury from cyclophosphamide [6]. Cancer-associated fibroblast-secreted FGF7 promotes ovarian cancer progression [7]. Pea sprout extract can enhance the expression of FGF7, potentially promoting hair growth [8]. In non-small lung cancer, CAFs with high FGF7 expression can robustly or moderately protect cancers [9]. FGF7 shows opposite effects in osteoporosis and osteoarthritis, protecting against osteoporosis but exacerbating osteoarthritis [10].

In conclusion, Fgf7 plays crucial roles in multiple biological processes and disease conditions. Its functions range from muscle regeneration, islet cell-virus interaction, bone-related cell regulation, to cancer progression and hair growth. The study of Fgf7 in different research models helps to understand its diverse biological functions and provides potential therapeutic targets for related diseases.

References:
1. Ma, Lu, Meng, Yingying, An, Yalong, Yang, Gongshe, Li, Xiao. 2024. Single-cell RNA-seq reveals novel interaction between muscle satellite cells and fibro-adipogenic progenitors mediated with FGF7 signalling. In Journal of cachexia, sarcopenia and muscle, 15, 1388-1403. doi:10.1002/jcsm.13484. https://pubmed.ncbi.nlm.nih.gov/38751367/
2. Zinkle, Allen, Mohammadi, Moosa. 2019. Structural Biology of the FGF7 Subfamily. In Frontiers in genetics, 10, 102. doi:10.3389/fgene.2019.00102. https://pubmed.ncbi.nlm.nih.gov/30809251/
3. Meng, Hao, Liao, Zhiying, Ji, Yanting, Xu, Tao, Liu, Huisheng. 2024. FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection. In Signal transduction and targeted therapy, 9, 104. doi:10.1038/s41392-024-01790-8. https://pubmed.ncbi.nlm.nih.gov/38654010/
4. Liu, Xiaoyu, Bai, Mingru, Sun, Yimin, Xie, Jing, Ye, Ling. 2021. FGF7-induced E11 facilitates cell-cell communication through connexin43. In International journal of biological sciences, 17, 3862-3874. doi:10.7150/ijbs.65240. https://pubmed.ncbi.nlm.nih.gov/34671204/
5. Milton, Christopher I, Selfe, Joanna, Aladowicz, Ewa, Kirkin, Vladimir, Shipley, Janet M. 2021. FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas. In Molecular oncology, 16, 1272-1289. doi:10.1002/1878-0261.13145. https://pubmed.ncbi.nlm.nih.gov/34850536/
6. Narla, Sridhar Tatarao, Rice, Lori, Ostrov, David, Duara, Joanne Lindsey, Bates, Carlton Matthew. . FGF7 peptide (FGF7p) mimetic mitigates bladder urothelial injury from cyclophosphamide. In Physiological reports, 10, e15241. doi:10.14814/phy2.15241. https://pubmed.ncbi.nlm.nih.gov/35388988/
7. Feng, Songwei, Ding, Bo, Dai, Zhu, Xiao, Zhongdang, Shen, Yang. 2024. Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter. In Journal of translational medicine, 22, 280. doi:10.1186/s12967-024-05085-y. https://pubmed.ncbi.nlm.nih.gov/38491511/
8. Grothe, Torsten, Wandrey, Franziska, Schuerch, Cornelia. 2019. [Not Available]. In Phytotherapy research : PTR, 34, 428-431. doi:10.1002/ptr.6528. https://pubmed.ncbi.nlm.nih.gov/31680356/
9. Hu, Haichuan, Piotrowska, Zofia, Hare, Patricia J, Niederst, Matthew J, Engelman, Jeffrey A. 2021. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. In Cancer cell, 39, 1531-1547.e10. doi:10.1016/j.ccell.2021.09.003. https://pubmed.ncbi.nlm.nih.gov/34624218/
10. Li, Liu-Cheng, Liu, Lei, Xu, Feng, Wang, Yu-Zhen, Mao, Kai-Li. . Unraveling the role of FGF7 in osteoarthritis and osteoporosis: Therapeutic implications and challenges. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 39, e70479. doi:10.1096/fj.202500226R. https://pubmed.ncbi.nlm.nih.gov/40134324/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research